Kate Schroder appointed scientific advisor of inflammatory disease treatment company

Associate Professor Kate Schroder has been appointed to the scientific advisory board of a new start-up company to develop treatments for inflammatory disorders including Parkinson’s disease and asthma.

Read more about the company via their website

Last updated:
13 June 2017